{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:31:35Z","timestamp":1787895095548,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-023-05363-w","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T05:02:46Z","timestamp":1686891766000},"page":"1743-1749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Refractory systemic lupus erythematosus with chylous effusion successfully treated with sirolimus: a case report and literature review"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6198-7123","authenticated-orcid":false,"given":"M.","family":"Banic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7162-7212","authenticated-orcid":false,"given":"G.","family":"Pavlisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3632-0896","authenticated-orcid":false,"given":"A.","family":"Hecimovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Grzelja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4940-0577","authenticated-orcid":false,"given":"B.","family":"Anic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5303-9353","authenticated-orcid":false,"given":"M.","family":"Samarzija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0171-764X","authenticated-orcid":false,"given":"M.","family":"Jankovic Makek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"key":"5363_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005382-199203000-00003","volume":"7","author":"HP Wiedemann","year":"1992","unstructured":"Wiedemann HP, Matthay RA (1992) Pulmonary manifestations of systemic lupus erythematosus. J Thorac Imaging 7:1\u201318. https:\/\/doi.org\/10.1097\/00005382-199203000-00003","journal-title":"J Thorac Imaging"},{"key":"5363_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1177\/0961203314555171","volume":"24","author":"BY Choi","year":"2015","unstructured":"Choi BY, Yoon MJ, Shin K et al (2015) Characteristics of pleural effusions in systemic lupus erythematosus: differential diagnosis of lupus pleuritis. Lupus 24:321\u2013326. https:\/\/doi.org\/10.1177\/0961203314555171","journal-title":"Lupus"},{"key":"5363_CR3","volume-title":"Chylothorax","author":"M Rudrappa","year":"2023","unstructured":"Rudrappa M, Paul M (2023) Chylothorax. StatPearls Publishing"},{"key":"5363_CR4","doi-asserted-by":"publisher","first-page":"210163","DOI":"10.1183\/20734735.0163-2021","volume":"18","author":"KU Rehman","year":"2022","unstructured":"Rehman KU, Sivakumar P (2022) Non-traumatic chylothorax: diagnostic and therapeutic strategies. Breathe 18:210163. https:\/\/doi.org\/10.1183\/20734735.0163-2021","journal-title":"Breathe"},{"key":"5363_CR5","doi-asserted-by":"publisher","first-page":"e23661","DOI":"10.1097\/MD.0000000000023661","volume":"99","author":"G-H Zhang","year":"2020","unstructured":"Zhang G-H, Zhang L-L, Wang Y-H, Shen W-B (2020) Clinical characteristics of systemic lupus erythematosus with chylothorax and\/or chylous ascites. Medicine 99:e23661. https:\/\/doi.org\/10.1097\/MD.0000000000023661","journal-title":"Medicine"},{"key":"5363_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X20953336","author":"L Peng","year":"2020","unstructured":"Peng L, Wu C, Hong R et al (2020) Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis. Ther Adv Musculoskelet Dis. https:\/\/doi.org\/10.1177\/1759720X20953336","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"5363_CR7","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00393-018-0545-z","volume":"78","author":"P Song","year":"2019","unstructured":"Song P, Zhang J, Shang C, Zhang L (2019) Refractory chylous pleural effusion with systemic lupus erythematosus. Z Rheumatol 78:797\u2013802. https:\/\/doi.org\/10.1007\/s00393-018-0545-z","journal-title":"Z Rheumatol"},{"key":"5363_CR8","doi-asserted-by":"publisher","DOI":"10.35465\/30.1.2022.pp90-94","author":"HI Majed","year":"2022","unstructured":"Majed HI, Nabil MT, Juahar I, Mohammed JA (2022) Chylothorax as a rare manifestation of systemic lupus erythematosus flare up\u2014case study. Rheumatology (Bulgaria). https:\/\/doi.org\/10.35465\/30.1.2022.pp90-94","journal-title":"Rheumatology (Bulgaria)"},{"key":"5363_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.rmcr.2017.07.005","volume":"22","author":"D Starobin","year":"2017","unstructured":"Starobin D, Guller V, Gurevich A, Tal S (2017) Minocycline induced lupus with yellow colored chylous exudative pleural effusion. Respir Med Case Rep 22:113\u2013116. https:\/\/doi.org\/10.1016\/j.rmcr.2017.07.005","journal-title":"Respir Med Case Rep"},{"key":"5363_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0140-6736(00)02480-6","volume":"356","author":"BD Kahan","year":"2000","unstructured":"Kahan BD (2000) Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. Lancet 356:194\u2013202. https:\/\/doi.org\/10.1016\/S0140-6736(00)02480-6","journal-title":"Lancet"},{"key":"5363_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13023-018-0946-8","volume":"13","author":"H-Y Yoon","year":"2018","unstructured":"Yoon H-Y, Hwang JJ, Kim DS, Song JW (2018) Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis. Orphanet J Rare Dis 13:204. https:\/\/doi.org\/10.1186\/s13023-018-0946-8","journal-title":"Orphanet J Rare Dis"},{"key":"5363_CR12","doi-asserted-by":"publisher","first-page":"g6679","DOI":"10.1136\/bmj.g6679","volume":"349","author":"GA Knoll","year":"2014","unstructured":"Knoll GA, Kokolo MB, Mallick R et al (2014) Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data. BMJ 349:g6679\u2013g6679. https:\/\/doi.org\/10.1136\/bmj.g6679","journal-title":"BMJ"},{"key":"5363_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-019-00810-9","author":"LS Nguyen","year":"2019","unstructured":"Nguyen LS, Vautier M, Allenbach Y et al (2019) Sirolimus and mTOR inhibitors: a review of side effects and specific management in solid organ transplantation. Drug Saf. https:\/\/doi.org\/10.1007\/s40264-019-00810-9","journal-title":"Drug Saf"},{"key":"5363_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.trre.2014.03.002","volume":"28","author":"B Kaplan","year":"2014","unstructured":"Kaplan B, Qazi Y, Wellen JR (2014) Strategies for the management of adverse events associated with mTOR inhibitors. Transplant Rev 28:126\u2013133. https:\/\/doi.org\/10.1016\/j.trre.2014.03.002","journal-title":"Transplant Rev"},{"key":"5363_CR15","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A et al (2019) 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78:736\u2013745. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215089","journal-title":"Ann Rheum Dis"},{"key":"5363_CR16","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","volume":"391","author":"Z-W Lai","year":"2018","unstructured":"Lai Z-W, Kelly R, Winans T et al (2018) Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial. Lancet 391:1186\u20131196. https:\/\/doi.org\/10.1016\/S0140-6736(18)30485-9","journal-title":"Lancet"},{"key":"5363_CR17","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1002\/art.22085","volume":"54","author":"D Fernandez","year":"2006","unstructured":"Fernandez D, Bonilla E, Mirza N et al (2006) Rapamycin reduces disease activity and normalizes T cell activation\u2013induced calcium fluxing in patients with systemic lupus erythematosus. Arthritis Rheum 54:2983\u20132988. https:\/\/doi.org\/10.1002\/art.22085","journal-title":"Arthritis Rheum"},{"key":"5363_CR18","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.4049\/jimmunol.0803600","volume":"182","author":"DR Fernandez","year":"2009","unstructured":"Fernandez DR, Telarico T, Bonilla E et al (2009) Activation of mammalian target of rapamycin controls the loss of TCR\u03b6 in lupus T cells through HRES-1\/Rab4-regulated lysosomal degradation. J Immunol 182:2063\u20132073. https:\/\/doi.org\/10.4049\/jimmunol.0803600","journal-title":"J Immunol"},{"key":"5363_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2019.00082","volume":"10","author":"P Eriksson","year":"2019","unstructured":"Eriksson P, Wallin P, Sj\u00f6wall C (2019) Clinical experience of sirolimus regarding efficacy and safety in systemic lupus erythematosus. Front Pharmacol 10:1\u20139. https:\/\/doi.org\/10.3389\/fphar.2019.00082","journal-title":"Front Pharmacol"},{"key":"5363_CR20","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3899\/jrheum.180507","volume":"45","author":"DYH Yap","year":"2018","unstructured":"Yap DYH, Tang C, Chan GCW et al (2018) Longterm data on sirolimus treatment in patients with lupus nephritis. J Rheumatol 45:1663\u20131670. https:\/\/doi.org\/10.3899\/jrheum.180507","journal-title":"J Rheumatol"},{"key":"5363_CR21","doi-asserted-by":"publisher","first-page":"108781","DOI":"10.1016\/j.clim.2021.108781","volume":"229","author":"P Piranavan","year":"2021","unstructured":"Piranavan P, Perl A (2021) Improvement of renal and non-renal SLE outcome measures on sirolimus therapy\u2014a 21-year follow-up study of 73 patients. C1 Immunol 229:108781. https:\/\/doi.org\/10.1016\/j.clim.2021.108781","journal-title":"C1 Immunol"},{"key":"5363_CR22","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1093\/rheumatology\/keaa645","volume":"60","author":"C Wu","year":"2021","unstructured":"Wu C, Wang Q, Xu D et al (2021) Sirolimus for patients with connective tissue disease-related refractory thrombocytopenia: a single-arm, open-label clinical trial. Rheumatology 60:2629\u20132634. https:\/\/doi.org\/10.1093\/rheumatology\/keaa645","journal-title":"Rheumatology"},{"key":"5363_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.rmed.2019.08.014","volume":"157","author":"LE Riley","year":"2019","unstructured":"Riley LE, Ataya A (2019) Clinical approach and review of causes of a chylothorax. Respir Med 157:7\u201313. https:\/\/doi.org\/10.1016\/j.rmed.2019.08.014","journal-title":"Respir Med"},{"key":"5363_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/797696","volume":"2013","author":"DE Soysal","year":"2013","unstructured":"Soysal DE, Hizar Turan S, Ozmen M et al (2013) A rare case of systemic lupus erythematosus with chylous ascites and chylothorax. Case Rep Rheumatol 2013:1\u20133. https:\/\/doi.org\/10.1155\/2013\/797696","journal-title":"Case Rep Rheumatol"},{"key":"5363_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1182\/blood-2015-07-657981","volume":"127","author":"KL Bride","year":"2016","unstructured":"Bride KL, Vincent T, Smith-Whitley K et al (2016) Sirolimus is effective in relapsed\/refractory autoimmune cytopenias: results of a prospective multi-institutional trial. Blood 127:17\u201328. https:\/\/doi.org\/10.1182\/blood-2015-07-657981","journal-title":"Blood"},{"key":"5363_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s40272-019-00337-7","volume":"21","author":"M Bevacqua","year":"2019","unstructured":"Bevacqua M, Baldo F, Pastore S et al (2019) Off-label use of sirolimus and everolimus in a pediatric center: a case series and review of the literature. Pediatr Drugs 21:185\u2013193. https:\/\/doi.org\/10.1007\/s40272-019-00337-7","journal-title":"Pediatr Drugs"},{"key":"5363_CR27","doi-asserted-by":"publisher","DOI":"10.2174\/1573397113666170704102444","author":"K Tselios","year":"2017","unstructured":"Tselios K, Urowitz MB (2017) Cardiovascular and pulmonary manifestations of systemic lupus erythematosus. Curr Rheumatol Rev. https:\/\/doi.org\/10.2174\/1573397113666170704102444","journal-title":"Curr Rheumatol Rev"},{"key":"5363_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/1756-185X.13001","volume":"20","author":"R Aithala","year":"2017","unstructured":"Aithala R, Alex AG, Danda D (2017) Pulmonary hypertension in connective tissue diseases: an update. Int J Rheum Dis 20:5\u201324. https:\/\/doi.org\/10.1111\/1756-185X.13001","journal-title":"Int J Rheum Dis"},{"key":"5363_CR29","doi-asserted-by":"publisher","first-page":"854941","DOI":"10.1155\/2012\/854941","volume":"2012","author":"A Dhala","year":"2012","unstructured":"Dhala A (2012) Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction. Clin Dev Immunol 2012:854941. https:\/\/doi.org\/10.1155\/2012\/854941","journal-title":"Clin Dev Immunol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05363-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05363-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05363-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T14:04:12Z","timestamp":1689343452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05363-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["5363"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05363-w","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"assertion":[{"value":"14 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}